| AK |
MAVYRET |
AbbVie Inc. |
$7,526,463 |
| AL |
FOCALIN XR |
Novartis Pharmaceuticals Corporation |
$26,580,202 |
| AR |
FOCALIN XR |
Novartis Pharmaceuticals Corporation |
$27,441,369 |
| AZ |
MAVYRET |
AbbVie Inc. |
$39,361,497 |
| CA |
ABILIFY |
Otsuka America Pharmaceuticals Inc. |
$402,645,829 |
| CO |
HUMIRA PEN |
AbbVie Inc. |
$33,238,648 |
| CT |
EPCLUSA 4 |
Gilead Sciences, Inc. |
$38,064,165 |
| DC |
GENVOYA TA |
Gilead Sciences, Inc. |
$27,703,403 |
| DE |
REMICADE |
Janssen Biotech, Inc. |
$441,530 |
| FL |
GENVOYA |
Gilead Sciences, Inc. |
$69,940,884 |
| GA |
METHYLPHEN |
SpecGx LLC |
$45,932,383 |
| HI |
INVEGA SUS |
Janssen Pharmaceuticals, Inc. |
$8,240,455 |
| IA |
FOCALIN XR |
Novartis Pharmaceuticals Corporation |
$7,343,680 |
| ID |
LATUDA |
Sunovion Pharmaceuticals Inc. |
$6,872,713 |
| IL |
HUMIRA - A |
AbbVie Inc. |
$79,791,099 |
| IN |
Lyrica (pr |
Parke-Davis Div of Pfizer Inc |
$39,690,429 |
| KS |
INVEGA SUS |
Janssen Pharmaceuticals, Inc. |
$8,030,921 |
| KY |
MAVYRET |
AbbVie Inc. |
$58,730,254 |
| LA |
VYVANSE |
Shire LLC |
$41,284,359 |
| MA |
SUBOXONE 8 |
Indivior Inc. |
$73,358,404 |
| MD |
GENVOYA TA |
Gilead Sciences, Inc. |
$36,075,640 |
| ME |
SUBOXONE |
Indivior Inc. |
$13,540,720 |
| MI |
LATUDA |
Sunovion Pharmaceuticals Inc. |
$78,752,958 |
| MN |
HUMIRA PEN |
AbbVie Inc. |
$35,255,482 |
| MO |
LATUDA |
Sunovion Pharmaceuticals Inc. |
$37,356,044 |
| MS |
NOVOLOG 10 |
Novo Nordisk |
$9,520,571 |
| MT |
HUMIRA 40 |
AbbVie Inc. |
$7,327,608 |
| NC |
VYVANSE |
Shire LLC |
$54,168,043 |
| ND |
NOVOLOG 10 |
Novo Nordisk |
$3,437,474 |
| NE |
FOCALIN XR |
Novartis Pharmaceuticals Corporation |
$8,605,088 |
| NH |
SUBOXONE |
Indivior Inc. |
$4,861,090 |
| NJ |
HUMIRA - A |
AbbVie Inc. |
$48,746,835 |
| NM |
MAVYRET 10 |
AbbVie Inc. |
$33,539,109 |
| NV |
HUMIRA - A |
AbbVie Inc. |
$13,699,434 |
| NY |
GENVOYA |
Gilead Sciences, Inc. |
$116,342,318 |
| OH |
HUMIRA - A |
AbbVie Inc. |
$103,591,345 |
| OK |
HUMIRA - A |
AbbVie Inc. |
$13,132,125 |
| OR |
HUMIRA - A |
AbbVie Inc. |
$30,846,525 |
| PA |
MAVYRET 10 |
AbbVie Inc. |
$126,225,742 |
| RI |
HUMIRA - A |
AbbVie Inc. |
$10,941,014 |
| SC |
VYVANSE |
Shire LLC |
$24,309,032 |
| SD |
ARANESP (d |
Amgen Inc |
$2,669,794 |
| TN |
VYVANSE |
Shire LLC |
$31,885,976 |
| TX |
NORDITROPI |
Novo Nordisk |
$60,011,161 |
| UT |
INVEGA SUS |
Janssen Pharmaceuticals, Inc. |
$7,215,932 |
| VA |
ONDANSETRO |
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
$22,637,386 |
| VT |
Suboxone S |
Indivior Inc. |
$17,445,893 |
| WA |
HUMIRA - A |
AbbVie Inc. |
$69,119,825 |
| WI |
HUMIRA - A |
AbbVie Inc. |
$52,716,986 |
| WV |
SUBOXONE 8 |
Indivior Inc. |
$37,003,078 |
| WY |
HUMIRA - A |
AbbVie Inc. |
$1,508,235 |